Bisdemethoxycurcumin exerts a cell-protective effect via JAK2/STAT3 signaling in a rotenone-induced Parkinson’s disease model in vitro
INTRODUCTION: Oxidative stress and cell apoptosis have both been suggested to be closely associated with the pathogenesis of Parkinson’s disease (PD). Previously, bisdemethoxycurcumin (BDMC) has been shown to exhibit several desirable characteristics as a candidate neuroprotective agent, including a...
| Published in: | Folia Histochemica et Cytobiologica |
|---|---|
| Main Authors: | Duanqun He, Shuangxi Chen, Zijian Xiao, Heng Wu, Guijuan Zhou, Chenlin Xu, Yunqian Chang, Yihui Li, Gang Wang, Ming Xie |
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2020-07-01
|
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/folia_histochemica_cytobiologica/article/view/66965 |
Similar Items
Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up‐regulating SIRT1
by: Yan Xu, et al.
Published: (2020-07-01)
by: Yan Xu, et al.
Published: (2020-07-01)
The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity
by: Britta Eggers, et al.
Published: (2025-01-01)
by: Britta Eggers, et al.
Published: (2025-01-01)
The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease
by: Mahesh Ramalingam, et al.
Published: (2019-09-01)
by: Mahesh Ramalingam, et al.
Published: (2019-09-01)
The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
by: Rhiannon Morris, et al.
Published: (2021-12-01)
by: Rhiannon Morris, et al.
Published: (2021-12-01)
Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway
by: ZhengHu Xu, et al.
Published: (2021-03-01)
by: ZhengHu Xu, et al.
Published: (2021-03-01)
JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01)
by: Dong Liang, et al.
Published: (2024-01-01)
Antiproliferative Ruthenium Complexes Containing Curcuminoid Ligands Tested In Vitro on Human Ovarian Tumor Cell Line A2780, towards Their Capability to Modulate the NF-<i>κ</i>BTranscription Factor, FGF-2 Growth Factor, and MMP-9 Pathway
by: Janka Leskovská, et al.
Published: (2022-07-01)
by: Janka Leskovská, et al.
Published: (2022-07-01)
Comparative Studies on the Antioxidant Profiles of Curcumin and Bisdemethoxycurcumin in Erythrocytes and Broiler Chickens
by: Jingfei Zhang, et al.
Published: (2019-11-01)
by: Jingfei Zhang, et al.
Published: (2019-11-01)
Fluorescent properties of chitosan-stabilized bisdemethoxycurcumin-silver nanoparticles: Synthesis and characterization
by: Shayma M. Ahmad, et al.
Published: (2024-08-01)
by: Shayma M. Ahmad, et al.
Published: (2024-08-01)
Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and –independent apoptosis via Smad or Akt signaling pathways in HOS cells
by: Cheng Huang, et al.
Published: (2020-03-01)
by: Cheng Huang, et al.
Published: (2020-03-01)
JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases
by: Yimeng Dai, et al.
Published: (2025-03-01)
by: Yimeng Dai, et al.
Published: (2025-03-01)
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01)
by: Maddison Lensing, et al.
Published: (2022-08-01)
JAK-STAT inhibitors in noninfectious uveitis – A review
by: Richa Pyare, et al.
Published: (2025-06-01)
by: Richa Pyare, et al.
Published: (2025-06-01)
Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage inflammation via the NRF2/HO‐1/NLRP3 pathway
by: Gang Jin, et al.
Published: (2024-02-01)
by: Gang Jin, et al.
Published: (2024-02-01)
Dietary bisdemethoxycurcumin supplementation attenuates lipopolysaccharide-induced damages on intestinal redox potential and redox status of broilers
by: Jingfei Zhang, et al.
Published: (2021-05-01)
by: Jingfei Zhang, et al.
Published: (2021-05-01)
Cannabidiol Alleviates Imiquimod-Induced Psoriasis by Inhibiting JAK2–STAT3 in a Mouse Model
by: Min-Seo Kim, et al.
Published: (2024-09-01)
by: Min-Seo Kim, et al.
Published: (2024-09-01)
Combined bisdemethoxycurcumin and potassium iodide-mediated antimicrobial photodynamic therapy
by: Teerasak Damrongrungruang, et al.
Published: (2023-07-01)
by: Teerasak Damrongrungruang, et al.
Published: (2023-07-01)
JAK-STAT Signaling in Autoimmunity and Cancer
by: Parveen S, et al.
Published: (2025-05-01)
by: Parveen S, et al.
Published: (2025-05-01)
Role of JAK-STAT Pathway in Broiler Chicks Fed with Chestnut Tannins
by: Annah Lee, et al.
Published: (2021-01-01)
by: Annah Lee, et al.
Published: (2021-01-01)
Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway
by: Hao-Xuan Zhang, et al.
Published: (2024-03-01)
by: Hao-Xuan Zhang, et al.
Published: (2024-03-01)
Effects of photodynamic therapy using bisdemethoxycurcumin combined with melatonin or acetyl-melatonin on C. Albicans
by: Maria Margarita D. Duterte, et al.
Published: (2024-10-01)
by: Maria Margarita D. Duterte, et al.
Published: (2024-10-01)
Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice
by: Yanjie Wang, et al.
Published: (2022-12-01)
by: Yanjie Wang, et al.
Published: (2022-12-01)
Small molecule drug discovery targeting the JAK-STAT pathway
by: You Lv, et al.
Published: (2024-06-01)
by: You Lv, et al.
Published: (2024-06-01)
The Many Faces of JAKs and STATs Within the COVID-19 Storm
by: Alice H. Grant, et al.
Published: (2021-07-01)
by: Alice H. Grant, et al.
Published: (2021-07-01)
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
by: Qianqian Yin, et al.
Published: (2021-09-01)
by: Qianqian Yin, et al.
Published: (2021-09-01)
Are peptidomimetics the compounds of choice for developing new modulators of the JAK-STAT pathway?
by: Alessia Cugudda, et al.
Published: (2024-06-01)
by: Alessia Cugudda, et al.
Published: (2024-06-01)
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
by: Yanhong Ni, et al.
Published: (2022-06-01)
by: Yanhong Ni, et al.
Published: (2022-06-01)
Inflammation and JAK/STAT Signaling: New Clues for the Treatment of COVID-19
by: Reza Shirazinia, et al.
Published: (2022-09-01)
by: Reza Shirazinia, et al.
Published: (2022-09-01)
Role of the JAK-STAT Pathway in Bovine Mastitis and Milk Production
by: Muhammad Zahoor Khan, et al.
Published: (2020-11-01)
by: Muhammad Zahoor Khan, et al.
Published: (2020-11-01)
JAK-STAT signaling pathway and diabetic complications
by: YU Ziman, ZHAO Bingjia, YANG Dan
Published: (2023-10-01)
by: YU Ziman, ZHAO Bingjia, YANG Dan
Published: (2023-10-01)
Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway
by: Jingyi Tan, et al.
Published: (2024-06-01)
by: Jingyi Tan, et al.
Published: (2024-06-01)
Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification
by: Huihuan Wu, et al.
Published: (2022-12-01)
by: Huihuan Wu, et al.
Published: (2022-12-01)
Bisdemethoxycurcumin Reduces Methicillin-Resistant <i>Staphylococcus aureus</i> Expression of Virulence-Related Exoproteins and Inhibits the Biofilm Formation
by: Shu Wang, et al.
Published: (2021-11-01)
by: Shu Wang, et al.
Published: (2021-11-01)
Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways
by: Tamaki Kurosawa, et al.
Published: (2015-01-01)
by: Tamaki Kurosawa, et al.
Published: (2015-01-01)
The potential roles of JAK/STAT signaling in the progression of osteoarthritis
by: Qingluo Zhou, et al.
Published: (2022-11-01)
by: Qingluo Zhou, et al.
Published: (2022-11-01)
STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
by: Ashley A. Able, et al.
Published: (2017-03-01)
by: Ashley A. Able, et al.
Published: (2017-03-01)
<i>Centipeda minima</i> Extract Inhibits Inflammation and Cell Proliferation by Regulating JAK/STAT Signaling in Macrophages and Keratinocytes
by: Yuanqiang Ma, et al.
Published: (2023-02-01)
by: Yuanqiang Ma, et al.
Published: (2023-02-01)
Ekspresja kinazy Jak3 i aktywacja białka Stat3 u chorych na reumatoidalne zapalenie stawów i spondyloartropatie zapalne
by: Andrzej Steciwko, et al.
Published: (2010-08-01)
by: Andrzej Steciwko, et al.
Published: (2010-08-01)
Bisdemethoxycurcumin chemoprevents 7,12-dimethylbenz(a)anthracene-induced mammary toxicity via modulation of oxidative processes
by: Adedoyin O. Adefisan-Adeoye, et al.
Published: (2025-03-01)
by: Adedoyin O. Adefisan-Adeoye, et al.
Published: (2025-03-01)
Characterization, Antioxidant and Cytotoxic Evaluation of Demethoxycurcumin and Bisdemethoxycurcumin from <i>Curcuma longa</i> Cultivated in Costa Rica
by: Andrea Mariela Araya-Sibaja, et al.
Published: (2024-01-01)
by: Andrea Mariela Araya-Sibaja, et al.
Published: (2024-01-01)
Similar Items
-
Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up‐regulating SIRT1
by: Yan Xu, et al.
Published: (2020-07-01) -
The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity
by: Britta Eggers, et al.
Published: (2025-01-01) -
The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease
by: Mahesh Ramalingam, et al.
Published: (2019-09-01) -
The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
by: Rhiannon Morris, et al.
Published: (2021-12-01) -
Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway
by: ZhengHu Xu, et al.
Published: (2021-03-01)
